ORiordan Anne 4
4 · Jazz Pharmaceuticals plc · Filed Aug 9, 2022
Insider Transaction Report
Form 4
ORiordan Anne
Director
Transactions
- Award
Ordinary Shares
[F1]2022-08-05+2,561→ 11,806 total - Sale
Ordinary Shares
[F2]2022-08-08$152.32/sh−1,089$165,877→ 10,717 total
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Signature
By: /s/Adam Guttmann, as attorney in fact For: Anne O'Riordan|2022-08-09